Results 261 to 270 of about 2,140,385 (376)
Proteome-scale prediction of molecular mechanisms underlying dominant genetic diseases. [PDF]
PLoS OneBadonyi M, Marsh JA.
europepmc +1 more source
Work participation in adults with rare genetic diseases - a scoping review. [PDF]
BMC Public Health, 2023 Velvin G +6 more
europepmc +1 more source
Molecular Oncology, EarlyView.Chronic TGF‐β exposure drives epithelial HCC cells from a senescent state to a TGF‐β resistant mesenchymal phenotype. This transition is characterized by the loss of Smad3‐mediated signaling, escape from senescence, enhanced invasiveness and metastatic potential, and upregulation of key resistance modulators such as MARK1 and GRM8, ultimately promoting
Minenur Kalyoncu +11 more
wiley +1 more source
Glycogen-storage disease in rats, a genetically determined deficiency of liver phosphorylase kinase [PDF]
, 1980 openalex +1 more source
The development and the genetic diseases of the ciliary body. [PDF]
Cell InsightLi B, Xie T, Nawy S, Shen Y.
europepmc +1 more source
Nanotechnology-enabled gene delivery for cancer and other genetic diseases. [PDF]
Expert Opin Drug Deliv, 2023 Jiang T, Gonzalez KM, Cordova LE, Lu J.
europepmc +1 more source
Molecular Oncology, EarlyView.We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau +11 more
wiley +1 more source
Screening of Living Kidney Donors for Genetic Diseases: PRO. [PDF]
Kidney360Caliskan Y, Lentine KL.
europepmc +1 more source